|
Specific activity of GSTmu in nmol/min/mg of protein (Ratio of the treated/control enzyme specific activities, 95% Confidence Intervals) |
|||||
| Sulforaphane |
BNF |
Curcumin |
DMF |
Control |
|
|
|
|||||
| Liver |
0.09 (0.39, 0.25–0.62)* |
0.20 (0.87, 0.71–1.1) |
0.23 (1.0, 0.79–1.3) |
0.29 (1.3, 1.0–1.6) |
0.23 |
| Kidney |
0.06 (3.0, 0.92–9.7) |
0.03 (1.5, 0.46–4.9) |
0.21 (10, 3.2–34)* |
0.02 (1.0, 0.25–4.0) |
0.02 |
| Prostate |
0.73 (1.9, 1.4–2.4)* |
0.76 (1.9, 1.5–2.5)* |
0.67 (1.7,1.4–2.1)* |
0.34 (0.87, 0.69–1.1) |
0.39 |
|
Data are mean values of 8–10 animals in each group * = P < 0.05 based on confidence intervals of the ratio of treated vs. control GST mu specific activities | |||||
Jones and Brooks BMC Cancer 2006 6:62 doi:10.1186/1471-2407-6-62 |
|||||